Temporary left ventricular assist devices as a bridge to heart transplantation.
Laura M SeeseGavin W HickeyMary E KeeblerMichael A MathierIbrahim S SultanThomas G GleasonYisi WangArman KilicPublished in: Journal of cardiac surgery (2020)
This study demonstrates that most patients waitlisted with a T-LVAD are successfully bridged to durable therapy or recover, and those bridged to OHT have acceptable posttransplant outcomes, particularly when T-RVADs are not required.
Keyphrases
- end stage renal disease
- left ventricular
- ejection fraction
- newly diagnosed
- chronic kidney disease
- heart failure
- peritoneal dialysis
- prognostic factors
- stem cells
- acute myocardial infarction
- type diabetes
- coronary artery disease
- aortic stenosis
- hypertrophic cardiomyopathy
- metabolic syndrome
- mesenchymal stem cells
- insulin resistance
- cardiac resynchronization therapy
- smoking cessation